Olink Bioscience and Sapphire Bioscience Sign a Distributorship Agreement for the Australian & New Zealand Market
News Apr 06, 2011
Olink Bioscience has signed a distributorship agreement with Sapphire Bioscience for the distribution of the Duolink® product line in Australia and New Zealand.
“Sapphire Bioscience is a well established company with a strong presence in the Life Sciences market in Australia & New Zealand. With its strive to represent companies focused on cutting edge research, Sapphire Bioscience is a natural partner for us” says Peter Karlberg, Director of Sales and Marketing at Olink Bioscience.
“We are very pleased with the collaboration with Olink and the opportunity to offer the Duolink product line. Duolink is an enabling and innovative tool for studying e.g. cell signaling or transduction pathways and fits very well with our goal to provide first class reagents to the research community in Australia & New Zealand” says Sue Goodman, Business Manager at Sapphire Bioscience.
The Duolink product line is based on Olink Bioscience’s proprietary in situ PLA® a proximity ligation assay technology that extends the capabilities of traditional protein techniques. These capabilities include direct detection of proteins, protein interactions and modifications with unparalleled specificity and sensitivity.
Target proteins are detected with single molecule resolution, allowing digital quantification and information about the exact localization of the target. Furthermore, the proteins can be studied at normal expression levels in fixed cells and tissue sections.
Using EBX reagents, researchers have converted the C-terminal carboxylic acid of peptides into a carbon-carbon triple bond - an alkyne (in chemical jargon a "decarboxylative alkynylation"). The alkyne moiety is a very valuable functional group that can be used to further modify the peptides.READ MORE